Association between inflammatory markers and cardiovascular risk factors in women from Kolkata, W.B, India;Associação entre marcadores inflamatórios e fatores de risco cardiovascular em mulheres de Kolkata, W.B, Índia

Arquivos Brasileiros de Cardiologia

Volumn 96, Issue 1, 2011, Pages 38-46

  Ganguli, Debdutta ^a   Das, Nilanjan ^a   Saha, Indranil ^a,d   Sanapala, Krishna Rao ^b   Chaudhuri, Debnath ^c   Ghosh, Saurabh ^b   Dey, Sanjit ^a  

^a UNIVERSITY OF CALCUTTA   (India)

^b INDIAN STATISTICAL INSTITUTE   (India)

^c ALL INDIA INSTITUTE OF HYGIENE AND PUBLIC HEALTH   (India)

^d R G KAR MEDICAL COLLEGE   (India)

Author keywords

Adiposity; Dyslipidemias; Inflammation; Leukocyte count; Reactive protein C; Risk factors; Women: India

Indexed keywords

APOLIPOPROTEIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN;

ADIPOSE TISSUE; ADULT; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONFIDENCE INTERVAL; CROSS-SECTIONAL STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; FEMALE; HUMAN; INDIAN; INFLAMMATION; LEUKOCYTE COUNT; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; SAMPLING; WAIST CIRCUMFERENCE;

ADULT; AGED; AGED, 80 AND OVER; APOLIPOPROTEIN A-I; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; CHOLESTEROL; CHOLESTEROL, HDL; CROSS-SECTIONAL STUDIES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; HUMANS; INDIA; LEUKOCYTE COUNT; MIDDLE AGED; PREVALENCE; RISK FACTORS; WAIST CIRCUMFERENCE;

EID: 79951621364     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.1590/S0066-782X2010005000165     Document Type: Article

References (39)

1. Koenig W, Sund M, Frohlich M, Fischer HG, Lowel H, Doring A, et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men. Results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation. 1999; 99 (2): 237-42.
2. Madjid M, Awan I, Willerson JT, Casscells SW. Leukocyte count and coronary heart disease : implications for risk assessment. J Am Coll Cardiol. 2004; 44 (10): 1945-56. (Pubitemid 39473277)
3. Yarnell JW, Baker IA, Sweetnam PM, Bainton D, O'Brien JR, Whitehead PJ, et al. Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease: The Caerphilly and Speedwell collaborative heart disease studies. Circulation. 1991; 83 (3): 836-44.
4. Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon RO 3rd, Criqui M, et al. Markers of inflammation and cardiovascular disease: Application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003; 107 (3): 499-511.
5. Ridker PM, Glynn RJ, Hennekens JS. C-reactive protein adds to the predictve value total and HDL cholesterol in determining risk of first myocardial infarction. Circulation. 1998; 97 (20): 2007-11. (Pubitemid 28243661)
6. Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation. 2003; 107 (3): 391-7.
7. Brown DW, Giles WH, Croft JB. White blood cell count: an independent predictor of coronary heart disease mortality among national cohort. J Clin Epidemiol. 2001; 54 (3): 316-22. (Pubitemid 32162036)
8. Yudkin JS, Stehouwer CDA, Erneis JJ, Coppack SW. C-reactive protein in healthy subjects: associations with obesity, insulin resistance and endothelial dysfunction: a potential role for cytokines originating from adipose tissue? Arterioscler Thromb Vasc Biol. 1999; 19 (4): 972-8.
9. Vikram NK, Misra A, Dwivedi M, Sharma R, Pandey RM, Luthra K, et al. Correlations of C-reactive protein levels with anthropometric profile,percentage of body fat and lipids in healthy adolescents and young adults in urban North India. Atherosclerosis. 2003; 168 (2): 305-13. (Pubitemid 36703330)
10. Oliveira AC, Oliveira AM, Adan LF, Oliveira NF, Silva AM, Ladeia AM. C-reactive protein and metabolic syndrome in youth: a strong relationship? Obesity. 2008; 16 (5): 1094-8.
11. Lemeshow S, Stroh G Jr. Sampling techniques for evaluating health parameters in developing countries. Washington DC: National Academy Press; 1988.
12. Barham D, Trinder P. An improved colour reagent for the determination of blood glucose by the oxidase system. Analyst. 1972; 97 (151): 142-5.
13. Trinder P. Determination of glucose in blood using glucose oxidase with an alternative oxygen acceptor. Ann Clin Biochem. 1969; 6: 24-7.
14. Tietz NW. Clinical guide to laboratory tests. 2nd ed. Philadelphia: WB Saunders Company; 1990. p. 554-6.
15. Friedewald WT, Levy RI, Fredrickson DS. Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge. Clin Chem. 1972; 18 (6): 499-502.
16. Tietz NW. Clinical guide to laboratory tests. Philadelphia: WB Saunders Company; 1995. p. 442-4.
17. Kronenberg F, Lobentanz EM, Konig P, Utermann G, Dieplinger H. Effect of sample storage on the measurement of lipoprotein[a], apolipoproteins B and A-IV, total and high-density lipoprotein cholesterol and triglycerides. J Lipid Res. 1994; 35 (7): 1318-28. (Pubitemid 2110236)
18. World Health Organization. The Asia-Pacific perspective: redefining obesity and its treatment. International diabetes Institute. Geneva; 2000.
19. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL, et al. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation and Treatment of High Blood Pressure: the JNC 7 Report. JAMA. 2003; 289 (19): 2560-72. (Pubitemid 37430158)
20. Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (adult treatment panel III). JAMA. 2001; 285 (19): 2486-97.
21. Mukherjee LK. Medical laboratory technology: a procedure manual for routine diagnostic tests. 3rd ed. New Delhi: McGraw Hill Publication; 1990.
22. Tracy RP, Psaty BM, Macy E, Bovill EG, Cushman M, Cornell ES, et al. Lifetime smoking exposure affects the association of C-reactive protein with cardiovascular disease risk factors and subclinical disease in healthy elderly subjects. Arterioscler Thromb Vasc Biol. 1997; 17 (10): 2167-76. (Pubitemid 28057118)
23. Mendall MA, Patel P, Asante M, Ballam L, Morris J, Strachan DP, et al. Relation of serum cytokine concentrations to cardiovascular risk factors and coronary heart disease. Heart. 1997; 78 (3): 273-7. (Pubitemid 27431736)
24. Hak AE, Stehouwer CDA, Blots ML, Polderman KH, Schalkwijk CG, Westendorp ICD, et al. Associations of C-reactive protein with measures of obesity, insulin resistance, and subclinical atherosclerosis in healthy, middle-aged women. Arterioscler Thromb Vasc Biol. 1999; 19 (8): 1986-91. (Pubitemid 29379933)
25. Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB. Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282 (22): 2131-5.
26. Ford ES. Body mass index, diabetes and C-reactive protein among US adults. Diabetes Care. 1999; 22 (12): 1071-7.
27. Lemieux I, Pascot A, Prud'homme D, Almeras N, Bogaty P, Nadeau A, et al. Elevated C-reactive protein: another component of the atherothrombotic profile of abdominal obesity. Arterioscler Thromb Vasc Biol. 2001; 21 (6): 961-7.
28. Mendall MA, Patel P, Ballam L, Strachan D, Northfield TC. C-reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study. BMJ. 1996; 312 (7038): 1061-5. (Pubitemid 26125131)
29. Birjmohun RS, Leuven SI, Levels JHM, Veer CV, Kuivenhoven JA, Meijers JCM, et al. High-density lipoprotein attenuates inflammation and coagulation response on endotoxin challenge in humans. Arterioscler Thromb Vasc Biol. 2007; 27 (5): 1153-8. (Pubitemid 46641971)
30. Rye KA, Barter PJ. Antiinflammatory actions of HDL:a new insight. Arterioscler Thromb Vasc Biol. 2008; 28 (11): 1890-1.
31. Nieto FJ, Szklo M, Folsom AR, Rock R, Mercuri M. Leukocyte count correlates in middle-aged adults: the Atherosclerosis Risk in Communities (ARIC) Study. Am J Epidemiol. 1992; 136 (5): 525-37.
32. Gokulakrishnan K, Deepa R, Sampathkumar R, Balasubhramanyam M, Mohan V. Association of leukocyte count and hs-CRP with metabolic abnormalities in subjects with normal glucose tolerance (CURES-64). J Assoc Physicians India. 2009; 57: 27-32.
33. Saito I, Folsom AR, Brancati FL, Duncan BB, Chambless LE, McGovern PG. Nontraditional risk factors for coronary heart disease incidence among persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Ann Intern Med. 2000; 133 (2): 81-91. (Pubitemid 30490408)
34. Ryu SY, Kim KS, Park J, Kang MG, Han MA. The association between circulating inflammatory markers and metabolic syndrome in Korean rural adults. J Prev Med Public Health. 2008; 41 (6): 413-8.
35. Sites CK, Toth MJ, Cushman M, L'Hommedieu GD, Tchernof A, Tracy RP, et al. Menopause-related differences in inflammation markers and their relationship to body fat distribution and insulin-stimulated glucose disposal. Fertil Steril. 2002; 77 (1): 128-35. (Pubitemid 34093904)
36. Folsom AR, Golden SH, Boland LL, Szklo M. Association of endogenous hormones with C-reactive protein, fibrinogen, and white blood count in post-menopausal women. Eur J Epidemiol. 2005; 20 (12): 1015-22. (Pubitemid 41752620)
37. Pradhan AD, Manson JE, Rossouw JE, Siscovick DS, Mouton CP, Rifai N, et al. Inflammatory biomarkers, hormone replacement therapy, and incident coronary heart disease: prospective analysis from the Women's Health Initiative Observational Study. JAMA. 2002; 288 (8): 980-7. (Pubitemid 34920463)
38. Libby P, Ridker PM, Maseri A. Inflammation and atherosclerosis. Circulation. 2002; 105 (9): 1135-43. (Pubitemid 34212626)
39. Patel VB, Robbins MA, Topol EJ. C-reactive protein: a 'golden marker' for inflammation and coronary artery disease. Cleve Clin J Med 2001; 68: 521-34.